Diallyl Disulfide: A Bioactive Garlic Compound with Anticancer Potential. 2022

Saikat Mitra, and Rajib Das, and Talha Bin Emran, and Rafiuddin Khan Labib, and Noor-E-Tabassum, and Fahadul Islam, and Rohit Sharma, and Islamudin Ahmad, and Firzan Nainu, and Kumarappan Chidambaram, and Fahad A Alhumaydhi, and Deepak Chandran, and Raffaele Capasso, and Polrat Wilairatana
Department of Pharmacy, Faculty of Pharmacy, University of Dhaka, Dhaka, Bangladesh.

Cancer is a life-threatening disease caused by the uncontrolled division of cells, which culminates in a solid mass of cells known as a tumor or liquid cancer. It is the leading cause of mortality worldwide, and the number of cancer patients has been increasing at an alarming rate, with an estimated 20 million cases expected by 2030. Thus, the use of complementary or alternative therapeutic techniques that can help prevent cancer has been the subject of increased attention. Garlic, the most widely used plant medicinal product, exhibits a wide spectrum of biological activities, including antibacterial, hypo-lipidemic, antithrombotic, and anticancer effects. Diallyl disulfide (DADS) is a major organosulfur compound contained within garlic. Recently, several experimental studies have demonstrated that DADS exhibits anti-tumor activity against many types of tumor cells, including gynecological cancers (cervical cancer, ovarian cancer), hematological cancers (leukemia, lymphoma), lung cancer, neural cancer, skin cancer, prostate cancer, gastrointestinal tract and associated cancers (esophageal cancer, gastric cancer, colorectal cancer), hepatocellular cancer cell line, etc. The mechanisms behind the anticancer action of DADS include epithelial-mesenchymal transition (EMT), invasion, and migration. This article aims to review the available information regarding the anti-cancer potential of DADS, as well as summarize its mechanisms of action, bioavailability, and pharmacokinetics from published clinical and toxicity studies.

UI MeSH Term Description Entries

Related Publications

Saikat Mitra, and Rajib Das, and Talha Bin Emran, and Rafiuddin Khan Labib, and Noor-E-Tabassum, and Fahadul Islam, and Rohit Sharma, and Islamudin Ahmad, and Firzan Nainu, and Kumarappan Chidambaram, and Fahad A Alhumaydhi, and Deepak Chandran, and Raffaele Capasso, and Polrat Wilairatana
January 2021, Evidence-based complementary and alternative medicine : eCAM,
Saikat Mitra, and Rajib Das, and Talha Bin Emran, and Rafiuddin Khan Labib, and Noor-E-Tabassum, and Fahadul Islam, and Rohit Sharma, and Islamudin Ahmad, and Firzan Nainu, and Kumarappan Chidambaram, and Fahad A Alhumaydhi, and Deepak Chandran, and Raffaele Capasso, and Polrat Wilairatana
February 2006, Biological & pharmaceutical bulletin,
Saikat Mitra, and Rajib Das, and Talha Bin Emran, and Rafiuddin Khan Labib, and Noor-E-Tabassum, and Fahadul Islam, and Rohit Sharma, and Islamudin Ahmad, and Firzan Nainu, and Kumarappan Chidambaram, and Fahad A Alhumaydhi, and Deepak Chandran, and Raffaele Capasso, and Polrat Wilairatana
November 2011, Indian journal of experimental biology,
Saikat Mitra, and Rajib Das, and Talha Bin Emran, and Rafiuddin Khan Labib, and Noor-E-Tabassum, and Fahadul Islam, and Rohit Sharma, and Islamudin Ahmad, and Firzan Nainu, and Kumarappan Chidambaram, and Fahad A Alhumaydhi, and Deepak Chandran, and Raffaele Capasso, and Polrat Wilairatana
August 2006, Molecular and cellular biochemistry,
Saikat Mitra, and Rajib Das, and Talha Bin Emran, and Rafiuddin Khan Labib, and Noor-E-Tabassum, and Fahadul Islam, and Rohit Sharma, and Islamudin Ahmad, and Firzan Nainu, and Kumarappan Chidambaram, and Fahad A Alhumaydhi, and Deepak Chandran, and Raffaele Capasso, and Polrat Wilairatana
January 2008, Asia Pacific journal of clinical nutrition,
Saikat Mitra, and Rajib Das, and Talha Bin Emran, and Rafiuddin Khan Labib, and Noor-E-Tabassum, and Fahadul Islam, and Rohit Sharma, and Islamudin Ahmad, and Firzan Nainu, and Kumarappan Chidambaram, and Fahad A Alhumaydhi, and Deepak Chandran, and Raffaele Capasso, and Polrat Wilairatana
April 2020, The Journal of nutritional biochemistry,
Saikat Mitra, and Rajib Das, and Talha Bin Emran, and Rafiuddin Khan Labib, and Noor-E-Tabassum, and Fahadul Islam, and Rohit Sharma, and Islamudin Ahmad, and Firzan Nainu, and Kumarappan Chidambaram, and Fahad A Alhumaydhi, and Deepak Chandran, and Raffaele Capasso, and Polrat Wilairatana
April 2005, Biological & pharmaceutical bulletin,
Saikat Mitra, and Rajib Das, and Talha Bin Emran, and Rafiuddin Khan Labib, and Noor-E-Tabassum, and Fahadul Islam, and Rohit Sharma, and Islamudin Ahmad, and Firzan Nainu, and Kumarappan Chidambaram, and Fahad A Alhumaydhi, and Deepak Chandran, and Raffaele Capasso, and Polrat Wilairatana
November 2021, International journal of molecular sciences,
Saikat Mitra, and Rajib Das, and Talha Bin Emran, and Rafiuddin Khan Labib, and Noor-E-Tabassum, and Fahadul Islam, and Rohit Sharma, and Islamudin Ahmad, and Firzan Nainu, and Kumarappan Chidambaram, and Fahad A Alhumaydhi, and Deepak Chandran, and Raffaele Capasso, and Polrat Wilairatana
March 2005, Phytotherapy research : PTR,
Saikat Mitra, and Rajib Das, and Talha Bin Emran, and Rafiuddin Khan Labib, and Noor-E-Tabassum, and Fahadul Islam, and Rohit Sharma, and Islamudin Ahmad, and Firzan Nainu, and Kumarappan Chidambaram, and Fahad A Alhumaydhi, and Deepak Chandran, and Raffaele Capasso, and Polrat Wilairatana
August 2021, Seminars in cancer biology,
Copied contents to your clipboard!